ArticleCureus2025
Successful Anesthetic Management Using Remimazolam in a Patient With Spinocerebellar Degeneration Undergoing Pulmonary Resection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinocerebellar degeneration (SCD) comprises a broad range of neurodegenerative disorders mainly characterized by cerebellar ataxia, and the prevention of perioperative respiratory complications is of great importance in patients with cerebellar ataxia. Clinical papers addressing anesthetic management using remimazolam in patients with SCD, specifically those undergoing pulmonary resection, are limited. A 79-year-old man with cortical cerebellar atrophy, a sporadic adult-onset SCD, was admitted for pulmonary resection for primary lung adenocarcinoma. He has experienced chronic aspiration caused by dysphagia, placing him at an increased risk for perioperative respiratory complications. Video-assisted right S6 segmentectomy was performed under general-epidural anesthesia using remimazolam, remifentanil, and local anesthetics. During emergence from anesthesia and tracheal extubation, a supraglottic airway was inserted while the double-lumen tube remained in place, after which the tube was removed under deep anesthesia. Subsequently, continuous infusion of remimazolam and remifentanil was terminated, and remimazolam was antagonized using flumazenil. After confirmation of spontaneous breathing and response to verbal commands, the supraglottic airway was removed without triggering the cough reflex or laryngospasm. The patient was fully conscious and did not experience re-sedation or respiratory depression. Furthermore, he had a good postoperative course and was discharged without respiratory complications or exacerbation of neurological symptoms. In conclusion, anesthetic management using remimazolam alongside careful airway management contributed to the successful management of a patient with SCD undergoing pulmonary resection. For a patient exhibiting cerebellar ataxia, remimazolam can be a useful anesthetic agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.